Effectiveness of sublingual immunotherapy with house dust mite drops in asthmatic children at different ages

Effectiveness of sublingual immunotherapy with house dust mite drops in asthmatic children at different ages

BackgroundRespiratory allergies in children, such as asthma and rhinitis, are becoming progressively common every year. Recent studies found that pediatric patients with asthma receiving regular medication and specific immunotherapy (SIT) had improved therapeutic outcomes in a wide age range. Howeve...

Full description

Bibliographic Details
Main Authors:	Tao Ai, Peilin Zhang, Ronghua Luo, Yinghong Fan, Wanmin Xia, Li Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Pediatrics
Subjects:	sublingual immunotherapy asthma children pulmonary function age difference
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2023.1170860/full

Similar Items

Benefit Effect of Sublingual Dust Mite Drops on the Control of Asthma in Children
by: Wang L, et al.
Published: (2021-07-01)

Efficacy and safety of sublingual immunotherapy in children aged 6-24 months with rhinitis and bronchial asthma sensitized to house dust mites
by: Olimpio Rodríguez-Santos, et al.
Published: (2015-11-01)

Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis
by: Mayuko Mizuno, et al.
Published: (2024-12-01)

Long-term efficacy of house dust mite sublingual immunotherapy on clinical and pulmonary function in patients with asthma and allergic rhinitis
by: Makoto Hoshino, MD, PhD, et al.
Published: (2024-05-01)

Adjuvant Effect of <i>Lactobacillus paracasei</i> in Sublingual Immunotherapy of Asthmatic Mice
by: Dhafer Alwayli, et al.
Published: (2024-11-01)

Dose dependence of efficacy but not of safety in sublingual immunotherapy
by: F. Frati, et al.
Published: (2016-02-01)

Effectiveness of allergen-specific immunotherapy in children with bronchial asthma sensitized to house dust mites
by: M.P. Prokhorova, et al.
Published: (2024-04-01)

Sublingual immunotherapy by Nanogold in mice model of asthma
by: Omid Javanmardghooghan, et al.
Published: (2021-04-01)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
by: Sophia Tsabouri, et al.
Published: (2017-04-01)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
by: Sophia Tsabouri, et al.
Published: (2017-09-01)

Low-dose sublingual immunotherapy compared to subcutaneous immunotherapy and conventional therapy in childhood asthma
by: Ariyanto Harsono
Published: (2016-10-01)

Sublingual Immunotherapy with House Dust Extract for House Dust-Mite Allergic Rhinitis in Children
by: Syuji Yonekura, et al.
Published: (2010-01-01)

Enhanced Efficacy of Sublingual Immunotherapy in Childhood Allergic Asthma by Probiotics
by: Anang Endaryanto, et al.
Published: (2018-04-01)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
by: Thomas Proctor, et al.
Published: (2020-04-01)

Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study
by: Masaaki Hamada, et al.
Published: (2023-10-01)

Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet
by: Incorvaia Cristoforo, et al.
Published: (2010-01-01)

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice
by: Žana Tempels-Pavlica, et al.
Published: (2024-02-01)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
by: Prapasri Kulalert, MD, PhD, et al.
Published: (2022-09-01)

The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis
by: Timothy West, MBBS, FRACP, et al.
Published: (2024-08-01)

Evaluation and Comparison of the Efficacy of Subcutaneous and Sublingual Immunotherapy for the Treatment of Allergic Asthma in Children
by: Vojko Berce, et al.
Published: (2024-06-01)

Characteristics of dust mite sublingual immunotherapy-associated adverse events in the early phase
by: Ming Chen, et al.
Published: (2022-12-01)

Clinical Efficacy of House Dust Mite-specific Immunotherapy in Asthmatic Children
by: Tzu-Chun Tsai, et al.
Published: (2010-02-01)

Efficacy of Sublingual Immunotherapy with Dermatophagoides Pteronyssinus: A Real-life Study
by: Tomic-Spiric Vesna, et al.
Published: (2016-04-01)

Patient compliance to sublingual immunotherapy for mite-induced allergic rhinitis: A retrospective study
by: Wen-Jin Wan, BN, et al.
Published: (2024-07-01)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
by: Tatsuya Fujii, et al.
Published: (2022-02-01)

Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite–Induced Allergic Rhinitis
by: Shaobing Xie, et al.
Published: (2021-07-01)

Efficacy of allergen-specific immunotherapy in children with atopic dermatitis sensitized to house dust mites
by: O.V. Mozyrska
Published: (2022-04-01)

Sublingual allergen immunotherapy for respiratory allergy: a systematic review
by: Carlos Blanco, et al.
Published: (2018-11-01)

Real-world assessment of anaphylaxis and eosinophilic esophagitis with 12 SQ house dust mite SLIT-tablet sublingual immunotherapy
by: Robert S. Zeiger, MD, PhD, et al.
Published: (2024-08-01)

Morning Versus Evening Dosing of Sublingual Immunotherapy in Allergic Asthma: A Prospective Study
by: Feng Liao, et al.
Published: (2022-06-01)

Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)Research in context
by: Pascal Demoly, et al.
Published: (2024-06-01)

Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials
by: Yi Li, et al.
Published: (2018-01-01)

Sublingual Immunotherapy in Children: An Updated Review
by: Chang-Hung Kuo, et al.
Published: (2009-04-01)

Sublingual Immunotherapy: Recent Advances
by: Enrico Compalati, et al.
Published: (2013-01-01)

STUDY OF THE PROPERTIES OF THE MIXED WATER/SALT HOUSE DUST MITE ALLERGEN AIMING TO DESIGN ITS SUBLINGUAL FORM
by: V. M. Berzhets, et al.
Published: (2018-06-01)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
by: Omar Ali Aboshady, et al.
Published: (2014-12-01)

Allergen Immunotherapy in Asthma
by: Kazuyuki Nakagome, et al.
Published: (2021-10-01)

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden
by: Cardell LO, et al.
Published: (2024-06-01)

Comparison between sublingual immunotherapy and subcutaneous immunotherapy in the treatment of pollen-induced vernal keratoconjunctivitis in children
by: Basem M Ibrahim, et al.
Published: (2018-01-01)

New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets
by: Gianfranco Vitiello, et al.
Published: (2020-06-01)